H-TAVPWNASW-OH

Ref. 3D-PP43212

Información del producto

• Nombre: H-TAVPWNASW-OH
• Sinónimos: NH2-Thr-Ala-Val-Pro-Trp-Asn-Ala-Ser-Trp-OH

Descripción

Peptide H-TAVPWNASW-OH is a Research Peptide with significant interest within the field academic and medical research. This peptide is available for purchase at Cymit Quimica in multiple sizes and with a specification of your choice. Recent citations using H-TAVPWNASW-OH include the following: An epitope-selective, transporter associated with antigen presentation (TAP)-1/2-independent pathway and a more general TAP-1/2-dependent antigen-processing SA Hammond , RP Johnson , SA Kalams - (Baltimore, Md.: 1950 , 1995 - journals.aai.orghttps://journals.aai.org/jimmunol/article-abstract/154/11/6140/28808 Induction of a major histocompatibility complex class I-restricted cytotoxic T-lymphocyte response to a highly conserved region of human immunodeficiency virus type RP Johnson , SA Hammond , A Trocha - Journal of , 1994 - Am Soc Microbiolhttps://journals.asm.org/doi/abs/10.1128/jvi.68.5.3145-3153.1994 Class I-restricted presentation of an HIV-1 gp41 epitope containing an N-linked glycosylation site. Implications for the mechanism of processing of viral envelope RL Ferris , C Buck , SA Hammond - (Baltimore, Md.: 1950 , 1996 - journals.aai.orghttps://journals.aai.org/jimmunol/article-abstract/156/2/834/111045 Processing of HIV-1 envelope glycoprotein for recognition by CD8+ cytolytic T lymphocytes: Implications for vaccine design RL Ferris - 1998 - search.proquest.comhttps://search.proquest.com/openview/e5ca91af41c6eeab23a6c4acca413689/1?pq-origsite=gscholar&cbl=18750&diss=y Class I-restricted presentation of an HIV-1 gp41 epitope containing an N-linked glycosylation site RJ Cotter - J Immunol, 1996 - scholar.archive.orghttps://scholar.archive.org/work/3ftcgluimfgc3iyb7a7y5x3bcq/access/wayback/https://watermark.silverchair.com/834.pdf?token=AQECAHi208BE49Ooan9kkhW_Ercy7Dm3ZL_9Cf3qfKAc485ysgAABH0wggR5BgkqhkiG9w0BBwagggRqMIIEZgIBADCCBF8GCSqGSIb3DQEHATAeBglghkgBZQMEAS4wEQQMlRhcQaSK2dc2vd8RAgEQgIIEMGsskgzmMVLYCI4SP-ruu465sYVCAlCBnuMNIcq-LRS1JticAAHWblC0JUvHgzbIsno_QUF-cpsKoE2c_KYtB-saKkKWdeX9JC6c8eReuaMRq5I4-A_Af3S3YpnpHDP78wag6A1gBieWNcTBIei2FiijfNBxNdKC7GO3MenE9gZiqv3JN_M252z6PuR8ahATQ3tgLvD1uzHONddIg71ITyI6ZhdCSR-qHU7G0UEzyTJyiwlnTrIg7d-waXybDQUIscmPu0md_n2ULuMEZx-buYyTWwLRHTFXkgm9cHVIsV8ndN7UsqkNTVRcQSVhAAN33gHGjExsCpodFb4rwecXw7Fb6dIEfebAcjG5trK7Pq-r8SxpfR0v7k33itMgxzGKMNqiSNBm9I-SnIy4h9p5Tr5VycArozeuX7M2LYB2cJVeMIi6NWW2w40TneyTXW_wGEuIbh3-bBJJxkNlyc7YrhDLYQ1ono4fFBix9hxhEbZLack2uaLnoRi9P0RAND70juBFgwm_wyCNVbNA0fITtZbN5b_rrMf9g7fs65xV1D9mVGWrqOl8ECrnMSHFPSi8JWt9kHEBLnVOXeLG1yqng6gbt8_jpr0fdiryTfNFwjYvx5r0u3X9sSLK8oTsDDnygX2LbnMXMJ_AeI7yUL6Dxjt8LyHls-scBlcF_Kdj8jNWu1He89cE0zwGJM4DeB2ID30XXk7Y0WatzPqJ8t_4eIr0hCyVoyW1Yt390MmnTRK9cWvTBcIkh6QBQ7Qh_RgZE5qrY0JgKV8vF88qXHT-g588hCgGIyU3M28JUcYQx7zJzBKkYcqsc9SgVdWY4USPAGSZTVBVno5e4Y-bGpQJdRY5wLgfzr6ipod88b82P08nJ3GitWZKh9cVORe1Ugryih4d2P2tAkjt3x2QHqwPQHDRLpzfBhHdY2U-2gPcR5BBfUsFJNedhtFfwuIQq-RdUJYQGi8acHggESPDQ1wtSaXR00P-PIMyv3swK78C6s1jJ93-RyvOUmSC6DRWACOcRXy4zOxdj5f--af_Owq78ggCTXRt51N9jnG4HZhijp7I_9Bx1wirB6p5gg9O98rj0Xs6Ra-t4FqRdR5FtzU1-bwFzbU5thlW9j0QWas8f7ob9QW0GKzRwW479xxyNwlGATU-YCeoWF_UaOPbvX4d3oNe-ov57xeXbSrx8n8y_CJHspxSXmZYs82bLeatWJVLJwKmCVPQr55WYSwqk5CFFSWgxW6fsSpx2x-uxzutRCh1DLh03coerZ3SbotQ956in09UtdeetzNEBQ9o_mZp5UZytpc7QemOdc8B9sTQleirUhHlDfA5H6oiYoQnQnHGL-OuIR73hZbHf1wf1Ll7AH0nmTVb8lkBfCveN71LKMmolrQHl6d438x8u1YigVkknwO3b7Zf2gyIUlAYWaZPeew Supplemental Table 1. List of HIV class I peptides. M End - pdfs.semanticscholar.orghttps://pdfs.semanticscholar.org/ed0f/0f087694817c860c5aad97fab618403c2847.pdf Systematic characterisation of cellular localisation and expression profiles of proteins containing MHC ligands AS Juncker, MV Larsen , N Weinhold , M Nielsen - PLoS , 2009 - journals.plos.orghttps://journals.plos.org/plosone/article?id=10.1371/journal.pone.0007448

• Marca: Biosynth